Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.49 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.84.
Market Cap
9.49T
Revenue
4.66T
Profits
186.63B
PE Ratio
50.84
Profit Margin
4.00%
Dividend Yield
0.37%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -1.12% | 1,860,531 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 640.48B | -1.57% | 7,303,027 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 456.18B | -1.81% | 4,330,707 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 368.94B | -2.33% | 8,522,576 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 354.59B | -1.49% | 2,516,546 | 450.53B |
| 6 | NVS | Novartis AG | 294.79B | -1.83% | 1,220,544 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 255.32B | -1.05% | 2,495,366 | 61.37B |
| 8 | AMGN | Amgen Inc. | 236.25B | -0.76% | 1,761,444 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 233.20B | -0.47% | 1,455,408 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 203.54B | -1.97% | 12,991,133 | 50.34B |
| 11 | ABT | Abbott Laboratories | 193.09B | -2.20% | 8,351,465 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.58B | 0.52% | 2,858,567 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.70B | -0.99% | 31,176,526 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.62B | 0.15% | 2,896,780 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.78B | 0.05% | 633,632 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.76B | -0.92% | 4,667,126 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 129.68B | -0.90% | 1,786,947 | 11.03B |
| 18 | SYK | Stryker Corporation | 123.56B | -2.29% | 2,166,471 | 25.84B |
| 19 | CVS | CVS Health Corporation | 118.84B | -1.48% | 4,327,738 | 412.65B |
| 20 | MDT | Medtronic plc | 115.16B | -2.23% | 5,747,010 | 36.36B |
| 21 | SNY | Sanofi | 107.86B | -1.28% | 2,291,004 | 55.89B |
| 22 | MCK | McKesson Corporation | 103.82B | -0.68% | 1,033,646 | 410.98B |
| 23 | GSK | GSK plc | 100.84B | -2.26% | 2,466,101 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 90.79B | -1.83% | 974,535 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.55B | -0.85% | 568,996 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.65B | -0.87% | 766,775 | 15.53B |
| 27 | CI | The Cigna Group | 73.37B | -1.14% | 1,228,573 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 67.64B | -3.11% | 16,249,980 | 21.00B |
| 29 | ARGX | argenx SE | 66.11B | 1.13% | 322,514 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.30B | -2.00% | 1,074,479 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.22B | -1.10% | 1,726,725 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.00B | -4.60% | 23,075,198 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.69B | -1.37% | 1,016,653 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.85B | -0.91% | 3,058,160 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.24B | -1.09% | 1,350,873 | 22.48B |
| 36 | NTRA | Natera, Inc. | 48.82B | 0.07% | 730,980 | 2.71B |
| 37 | RVMD | Revolution Medicines, Inc. | 47.40B | 2.65% | 3,355,005 | - |
| 38 | HUM | Humana Inc. | 47.15B | 0.40% | 899,254 | 145.68B |
| 39 | VEEV | Veeva Systems Inc. | 45.83B | 15.20% | 4,997,497 | 3.46B |
| 40 | MDLN | Medline Inc. | 45.55B | 0.20% | 7,796,132 | 29.94B |
| 41 | A | Agilent Technologies, Inc. | 44.46B | 1.68% | 3,184,194 | 7.37B |
| 42 | HLN | Haleon plc | 44.23B | -1.28% | 10,238,179 | 14.80B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.84B | -0.79% | 4,720,972 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 43.19B | 0.33% | 1,225,016 | 16.98B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.94B | -1.51% | 340,458 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.35B | -0.88% | 225,067 | 6.13B |
| 47 | WAT | Waters Corporation | 41.39B | 1.71% | 741,534 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.60B | 0.19% | 2,093,679 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.16B | -0.61% | 716,508 | 10.86B |
| 50 | ILMN | Illumina, Inc. | 34.38B | 1.27% | 1,937,085 | 4.49B |
| 51 | RMD | ResMed Inc. | 34.01B | 0.03% | 1,588,289 | 5.65B |
| 52 | DXCM | DexCom, Inc. | 33.69B | 0.37% | 3,025,914 | 4.97B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 32.74B | -1.13% | 2,961,965 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.73B | 0.19% | 497,282 | 10.03B |
| 55 | CNC | Centene Corporation | 32.27B | -0.21% | 3,647,617 | 180.30B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.65B | -1.02% | 1,293,205 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 31.00B | -3.22% | 3,381,504 | 9.53B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.20B | 0.64% | 146,040 | 4.13B |
| 59 | BNTX | BioNTech SE | 27.98B | -1.03% | 1,551,124 | 3.03B |
| 60 | LH | Labcorp Holdings Inc. | 27.29B | 0.24% | 671,364 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 27.14B | 2.26% | 4,920,767 | 7.53M |
| 62 | DGX | Quest Diagnostics Incorporated | 27.00B | -0.16% | 833,312 | 11.56B |
| 63 | INSM | Insmed Incorporated | 26.51B | -2.41% | 1,055,878 | 1.14B |
| 64 | PHG | Koninklijke Philips N.V. | 26.44B | -0.26% | 548,510 | 20.18B |
| 65 | INCY | Incyte Corporation | 25.89B | -0.30% | 700,345 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.36B | -1.09% | 365,868 | 3.33B |
| 67 | STE | STERIS plc | 22.71B | -1.60% | 532,577 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.64B | 2.17% | 390,994 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.61B | -1.40% | 1,504,456 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.56B | -2.35% | 1,178,018 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.17B | 1.04% | 1,866,280 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.40B | 0.24% | 6,462,576 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.97B | -1.87% | 1,351,031 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.07B | -1.21% | 196,548 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.38B | -0.36% | 189,524 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.30B | 0.73% | 4,765,467 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.85B | -0.43% | 730,149 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.48B | -0.66% | 687,200 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 15.38B | -0.87% | 976,939 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.47B | 2.66% | 1,932,714 | 2.91B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.15B | 0.44% | 901,312 | 4.00B |
| 82 | COO | The Cooper Companies, Inc. | 13.84B | -2.37% | 1,519,879 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.69B | -1.50% | 1,489,242 | 2.44B |
| 84 | BAX | Baxter International Inc. | 13.41B | -2.15% | 4,487,405 | 11.47B |
| 85 | ICLR | ICON Public Limited Company | 13.09B | 0.47% | 279,773 | 8.29B |
| 86 | TEM | Tempus AI, Inc. | 12.75B | 3.23% | 6,146,450 | 1.43B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.69B | -0.73% | 3,197,632 | 14.37B |
| 88 | PEN | Penumbra, Inc. | 12.64B | -0.63% | 476,699 | 1.50B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.64B | -2.40% | 639,571 | 830.81M |
| 90 | BMRN | BioMarin Pharmaceutical Inc. | 12.64B | -0.49% | 1,245,964 | 3.41B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.56B | 0.89% | 221,851 | 1.28B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.51B | -0.59% | 857,456 | 669.50M |
| 93 | FMS | Fresenius Medical Care AG | 12.39B | -0.56% | 534,261 | 22.19B |
| 94 | SNN | Smith & Nephew plc | 12.26B | -0.58% | 1,106,190 | 6.30B |
| 95 | ELAN | Elanco Animal Health Incorporated | 12.24B | -2.35% | 4,093,383 | 5.02B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 12.14B | -0.13% | 1,364,607 | 1.66B |
| 97 | EHC | Encompass Health Corporation | 11.80B | -1.00% | 858,127 | 6.21B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.43B | 0.70% | 4,836,607 | - |
| 99 | DVA | DaVita Inc. | 11.41B | -0.65% | 486,216 | 14.01B |
| 100 | TECH | Bio-Techne Corporation | 11.36B | 0.12% | 1,683,886 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.28B | -0.19% | 801,173 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 11.08B | -0.67% | 845,977 | 3.14B |
| 103 | ABVX | ABIVAX Société Anonyme | 10.89B | -1.91% | 1,074,233 | 5.67M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.83B | -1.64% | 1,089,856 | 67.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.80B | -0.42% | 586,214 | 776.57M |
| 106 | GKOS | Glaukos Corporation | 10.72B | 0.74% | 442,291 | 612.84M |
| 107 | KRYS | Krystal Biotech, Inc. | 10.58B | -0.64% | 181,370 | 440.48M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.43B | 0.33% | 243,429 | 2.59B |
| 109 | IONS | Ionis Pharmaceuticals, Inc. | 10.37B | -1.47% | 1,625,118 | 874.09M |
| 110 | MOH | Molina Healthcare, Inc. | 10.35B | -1.82% | 423,694 | 42.47B |
| 111 | RGEN | Repligen Corporation | 10.27B | 0.96% | 611,892 | 785.10M |
| 112 | PRAX | Praxis Precision Medicines, Inc. | 10.27B | -2.52% | 242,856 | 7.46M |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 10.25B | -0.49% | 1,507,871 | 3.50B |
| 114 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 1,137,230 | - |
| 115 | UHS | Universal Health Services, Inc. | 10.17B | -3.42% | 574,807 | 18.11B |
| 116 | HSIC | Henry Schein, Inc. | 10.06B | -0.11% | 784,776 | 13.60B |
| 117 | ENSG | The Ensign Group, Inc. | 10.03B | -3.93% | 381,530 | 5.49B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 10.00B | -4.24% | 595,314 | 105.00M |
| 119 | PODD | Insulet Corporation | 9.95B | 0.02% | 1,338,057 | 3.05B |
| 120 | AVTR | Avantor, Inc. | 9.88B | 0.76% | 5,996,883 | 6.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.67B | -1.32% | 381,477 | 281.99M |
| 122 | TWST | Twist Bioscience Corporation | 9.60B | 2.03% | 1,252,240 | 431.80M |
| 123 | OSCR | Oscar Health, Inc. | 9.27B | -3.81% | 5,182,076 | 15.32B |
| 124 | PCVX | Vaxcyte, Inc. | 9.10B | 0.11% | 611,452 | - |
| 125 | IMVT | Immunovant, Inc. | 9.05B | -0.16% | 667,014 | - |
| 126 | QGEN | Qiagen N.V. | 9.05B | 0.88% | 1,582,318 | 2.10B |
| 127 | BRKR | Bruker Corporation | 9.03B | 3.84% | 2,433,358 | 3.50B |
| 128 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.01% | 1,058,993 | 42.16M |
| 129 | IBRX | ImmunityBio, Inc. | 8.90B | 1.82% | 11,603,141 | 165.79M |
| 130 | TXG | 10x Genomics, Inc. | 8.45B | 0.92% | 2,332,299 | 616.91M |
| 131 | ATR | AptarGroup, Inc. | 8.45B | -1.76% | 291,759 | 3.93B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 8.25B | 0.01% | 1,165,262 | - |
| 133 | ALKS | Alkermes plc | 8.20B | -0.53% | 2,119,364 | 1.67B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.90B | 1.25% | 1,221,793 | 799.54M |
| 135 | HQY | HealthEquity, Inc. | 7.81B | -10.56% | 3,219,731 | 1.36B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.75B | 0.59% | 311,064 | 239.92M |
| 137 | HNGE | Hinge Health, Inc. | 7.49B | 2.60% | 1,635,507 | 720.06M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.45B | -1.64% | 10,904,093 | 989.61M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.39B | 6.13% | 8,624,315 | 2.58B |
| 140 | SRRK | Scholar Rock Holding Corporation | 7.22B | -1.30% | 596,909 | - |
| 141 | PACS | PACS Group, Inc. | 7.00B | -0.34% | 508,735 | 5.55B |
| 142 | CGON | CG Oncology, Inc. | 7.00B | 0.75% | 328,892 | 6.23M |
| 143 | GRFS | Grifols, S.A. | 7.00B | -1.01% | 545,320 | 8.48B |
| 144 | ERAS | Erasca, Inc. | 6.82B | 1.78% | 4,221,806 | - |
| 145 | CHE | Chemed Corporation | 6.77B | -5.16% | 363,763 | 2.60B |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.56B | -0.35% | 1,614,802 | 1.56B |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | 1.26% | 402,119 | 618.07M |
| 148 | COGT | Cogent Biosciences, Inc. | 6.44B | 1.01% | 1,636,556 | - |
| 149 | ORKA | Oruka Therapeutics, Inc. | 6.39B | -2.92% | 614,611 | - |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.36B | 0.60% | 911,627 | 591.33M |
| 151 | BLTE | Belite Bio, Inc | 6.32B | 0.20% | 106,496 | - |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.27B | 0.11% | 1,100,926 | 3.12B |
| 153 | LQDA | Liquidia Corporation | 6.26B | -1.99% | 548,536 | 450.91M |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.24B | 0.70% | 601,232 | 1.90M |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.23B | 1.42% | 413,247 | 840.85M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.12B | -0.70% | 559,310 | 5.32B |
| 157 | STVN | Stevanato Group S.p.A. | 6.09B | -0.36% | 306,263 | 1.40B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 6.00B | -2.92% | 586,951 | 7.50M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.99B | -1.21% | 746,329 | 1.01B |
| 160 | RDNT | RadNet, Inc. | 5.93B | -1.45% | 528,463 | 2.27B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.89B | 0.11% | 1,416,931 | - |
| 162 | TFX | Teleflex Incorporated | 5.84B | -0.74% | 327,668 | 2.25B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.74B | 0.24% | 1,186,880 | 13.39M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | -1.16% | 206,320 | 290.54M |
| 165 | SHC | Sotera Health Company | 5.56B | -0.31% | 1,775,422 | 1.22B |
| 166 | MMED | MiniMed Group, Inc. | 5.48B | 0.10% | 1,306,306 | 3.10B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.35B | -1.10% | 572,032 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.12B | 0.51% | 879,334 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.87B | -1.02% | 1,018,664 | - |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.85B | 0.08% | 445,429 | 148.00K |
| 171 | WAY | Waystar Holding Corp. | 4.84B | 4.47% | 2,187,988 | 1.21B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | -0.43% | 995,598 | - |
| 173 | HAE | Haemonetics Corporation | 4.78B | -1.50% | 592,815 | 1.35B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.70B | 1.23% | 2,502,470 | 1.58B |
| 175 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.67B | 0.27% | 1,988,641 | -665.00K |
| 176 | CELC | Celcuity Inc. | 4.56B | -1.94% | 457,213 | - |
| 177 | DOCS | Doximity, Inc. | 4.56B | 3.44% | 2,466,136 | 655.57M |
| 178 | BLLN | BillionToOne, Inc. | 4.49B | -1.11% | 670,296 | 397.41M |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.43B | -0.60% | 523,765 | - |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.42B | -0.72% | 561,612 | 2.29B |
| 181 | LIVN | LivaNova PLC | 4.41B | 0.08% | 611,113 | 1.47B |
| 182 | NVST | Envista Holdings Corporation | 4.41B | -1.29% | 1,451,157 | 2.86B |
| 183 | ICUI | ICU Medical, Inc. | 4.38B | -2.50% | 263,654 | 2.16B |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.26B | -0.75% | 2,037,392 | 53.81M |
| 185 | ITGR | Integer Holdings Corporation | 4.26B | 0.09% | 461,011 | 1.84B |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.26B | -0.21% | 2,394,416 | 10.35M |
| 187 | MANE | Veradermics, Incorporated | 4.25B | -0.96% | 260,329 | - |
| 188 | ADPT | Adaptive Biotechnologies Corporation | 4.22B | 1.07% | 2,078,789 | 308.08M |
| 189 | HTFL | HeartFlow, Inc. | 4.18B | -1.72% | 1,439,326 | 212.07M |
| 190 | INDV | Indivior Pharmaceuticals, Inc. | 4.17B | -1.47% | 1,220,380 | 1.33B |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 4.03B | 0.46% | 534,276 | 234.13M |
| 192 | ABCL | AbCellera Biologics Inc. | 4.02B | 1.31% | 3,988,713 | 66.17M |
| 193 | LEGN | Legend Biotech Corporation | 3.97B | -0.87% | 1,015,544 | 1.27B |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.95B | -1.51% | 2,205,811 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.41% | 700,064 | 3.60M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.90B | -0.55% | 786,473 | 117.00M |
| 197 | IRTC | iRhythm Holdings, Inc. | 3.83B | -2.37% | 402,524 | 825.34M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.81B | 2.20% | 73,769 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | 2.23% | 7,434,842 | 324.97M |
| 200 | GRAL | GRAIL, Inc. | 3.68B | 3.66% | 742,897 | 165.26M |
| 201 | VCYT | Veracyte, Inc. | 3.64B | 2.17% | 1,243,377 | 561.90M |
| 202 | OGN | Organon & Co. | 3.61B | -0.07% | 3,155,116 | 6.13B |
| 203 | OPCH | Option Care Health, Inc. | 3.59B | -0.25% | 1,413,649 | 5.69B |
| 204 | GPCR | Structure Therapeutics Inc. | 3.51B | -0.26% | 318,893 | - |
| 205 | NHC | National HealthCare Corporation | 3.48B | -1.26% | 122,628 | 1.56B |
| 206 | PLSE | Pulse Biosciences, Inc. | 3.46B | 0.96% | 222,379 | 1.19M |
| 207 | QURE | uniQure N.V. | 3.44B | -2.73% | 711,954 | 18.67M |
| 208 | IMNM | Immunome, Inc. | 3.28B | 0.42% | 920,721 | 4.02M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.20B | -2.23% | 626,804 | 7.12M |
| 210 | MBX | MBX Biosciences, Inc. | 3.20B | -0.55% | 263,495 | - |
| 211 | TMDX | TransMedics Group, Inc. | 3.18B | -0.51% | 357,402 | 668.47M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 3.18B | -0.27% | 449,352 | 158.00K |
| 213 | IRON | Disc Medicine, Inc. | 3.17B | -0.15% | 324,129 | - |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.16B | 1.80% | 876,367 | 606.33M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.13B | -1.07% | 2,204,608 | 463.98M |
| 216 | WRBY | Warby Parker Inc. | 3.12B | -0.82% | 1,287,977 | 911.61M |
| 217 | SLS | SELLAS Life Sciences Group, Inc. | 3.07B | 10.78% | 12,076,467 | - |
| 218 | BEAM | Beam Therapeutics Inc. | 3.05B | 0.96% | 1,268,873 | 156.04M |
| 219 | AVAH | Aveanna Healthcare Holdings Inc. | 3.02B | 1.47% | 3,716,917 | 2.60B |
| 220 | ZLAB | Zai Lab Limited | 3.01B | 3.03% | 597,324 | 449.61M |
| 221 | ALMS | Alumis Inc. | 3.00B | -1.74% | 478,312 | 7.40M |
| 222 | BKD | Brookdale Senior Living Inc. | 2.89B | -0.90% | 3,373,476 | 2.93B |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.81B | -1.18% | 1,322,884 | 3.37B |
| 224 | ALHC | Alignment Healthcare, Inc. | 2.81B | -2.45% | 4,699,860 | 4.58B |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.79B | 0.62% | 1,214,116 | 36.77M |
| 226 | AXGN | Axogen, Inc. | 2.78B | 0.29% | 951,476 | 251.17M |
| 227 | RGC | Regencell Bioscience Holdings Limited | 2.74B | 0.36% | 73,507 | - |
| 228 | ATAI | AtaiBeckley Inc. | 2.73B | -0.54% | 3,034,219 | 4.47M |
| 229 | CDNA | CareDx, Inc. | 2.71B | 2.75% | 1,250,756 | 458.09M |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.71B | -1.57% | 839,734 | 71.13M |
| 231 | PRVA | Privia Health Group, Inc. | 2.66B | -1.00% | 943,467 | 2.36B |
| 232 | WGS | GeneDx Holdings Corp. | 2.66B | -1.16% | 354,189 | 454.43M |
| 233 | PHVS | Pharvaris N.V. | 2.60B | - | 765,047 | - |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | -0.68% | 1,142,509 | 717.00M |
| 235 | PGEN | Precigen, Inc. | 2.57B | -3.10% | 4,054,647 | 85.72M |
| 236 | SUPN | Supernus Pharmaceuticals, Inc. | 2.57B | -1.54% | 464,873 | 830.44M |
| 237 | NEOG | Neogen Corporation | 2.56B | 0.34% | 1,372,017 | 870.40M |
| 238 | TRVI | Trevi Therapeutics, Inc. | 2.56B | 0.22% | 1,231,223 | - |
| 239 | NKTR | Nektar Therapeutics | 2.55B | 1.06% | 340,346 | 54.59M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.52B | 0.41% | 2,478,940 | 940.61M |
| 241 | ATRC | AtriCure, Inc. | 2.51B | 2.28% | 766,317 | 569.62M |
| 242 | VERA | Vera Therapeutics, Inc. | 2.49B | -6.03% | 2,706,275 | - |
| 243 | NUVB | Nuvation Bio Inc. | 2.45B | 0.43% | 3,530,095 | 169.90M |
| 244 | KOD | Kodiak Sciences Inc. | 2.45B | -0.53% | 369,554 | - |
| 245 | RAPP | Rapport Therapeutics, Inc. | 2.44B | -3.18% | 382,832 | 20.00M |
| 246 | BHVN | Biohaven Ltd. | 2.43B | -4.90% | 5,426,637 | - |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.43B | -1.80% | 304,472 | 1.10B |
| 248 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 0.49% | 439,506 | - |
| 249 | NEO | NeoGenomics, Inc. | 2.39B | 7.31% | 5,097,628 | 766.30M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.38B | 0.46% | 1,427,216 | 52.06M |
| 251 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -0.40% | 219,054 | 1.46B |
| 252 | BHC | Bausch Health Companies Inc. | 2.36B | -3.23% | 2,721,619 | 10.85B |
| 253 | UFPT | UFP Technologies, Inc. | 2.32B | -1.52% | 102,268 | 631.64M |
| 254 | BFLY | Butterfly Network, Inc. | 2.32B | 0.93% | 4,293,741 | 112.14M |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.53% | 497,428 | 959.90M |
| 256 | COAG | Hemab Therapeutics Holdings, Inc. | 2.31B | 0.61% | 354,963 | - |
| 257 | MLYS | Mineralys Therapeutics, Inc. | 2.30B | 0.46% | 420,746 | - |
| 258 | ALMR | Alamar Biosciences, Inc. | 2.29B | -3.17% | 281,357 | 100.42M |
| 259 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 10.95% | 7,918,665 | 1.97B |
| 260 | NBTX | Nanobiotix S.A. | 2.28B | 1.48% | 347,804 | 38.27M |
| 261 | MESO | Mesoblast Limited | 2.25B | 7.96% | 541,630 | 120.25M |
| 262 | CLOV | Clover Health Investments, Corp. | 2.25B | -0.47% | 2,937,491 | 2.48B |
| 263 | URGN | UroGen Pharma Ltd. | 2.22B | -0.96% | 559,747 | 188.73M |
| 264 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 1.01% | 3,557,132 | 3.64B |
| 265 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.39% | 838,333 | 311.51M |
| 266 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.17B | -5.96% | 3,170,535 | 208.78M |
| 267 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -2.59% | 232,748 | - |
| 268 | ADUS | Addus HomeCare Corporation | 2.16B | -2.24% | 208,389 | 1.48B |
| 269 | HCM | HUTCHMED (China) Limited | 2.16B | 0.53% | 89,120 | 549.12M |
| 270 | XNCR | Xencor, Inc. | 2.15B | 1.55% | 1,552,933 | 104.97M |
| 271 | ESTA | Establishment Labs Holdings Inc. | 2.14B | -0.90% | 229,749 | 245.82M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 2.13B | -1.27% | 658,972 | 1.00M |
| 273 | MD | Pediatrix Medical Group, Inc. | 2.13B | -0.56% | 544,485 | 1.95B |
| 274 | TRLV | Trulieve Cannabis Corp. | 2.12B | -3.50% | 913,899 | 1.14B |
| 275 | ADMA | ADMA Biologics, Inc. | 2.12B | -1.56% | 1,496,256 | 512.28M |
| 276 | VCEL | Vericel Corporation | 2.11B | -2.97% | 533,420 | 306.30M |
| 277 | STOK | Stoke Therapeutics, Inc. | 2.10B | -1.51% | 939,328 | 27.59M |
| 278 | NVCR | NovoCure Limited | 2.09B | 0.56% | 532,968 | 699.19M |
| 279 | ZYME | Zymeworks Inc. | 2.06B | -1.01% | 625,125 | 37.13M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 0.85% | 883,837 | 98.34M |
| 281 | CMPS | COMPASS Pathways plc | 2.03B | 0.21% | 1,656,667 | - |
| 282 | GENB | Generate Biomedicines, Inc. | 2.02B | -2.29% | 2,858,496 | 26.48M |
| 283 | PRGO | Perrigo Company plc | 1.99B | -2.64% | 2,736,489 | 4.14B |
| 284 | PGNY | Progyny, Inc. | 1.98B | -1.93% | 1,161,823 | 1.31B |
| 285 | GHRS | GH Research PLC | 1.97B | -1.24% | 73,500 | - |
| 286 | ASTH | Astrana Health, Inc. | 1.97B | -0.52% | 280,934 | 3.84B |
| 287 | KARD | Kardigan, Inc. | 1.94B | -1.79% | 546,649 | - |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.94B | -1.00% | 2,187,198 | 5.49M |
| 289 | FBRX | Forte Biosciences, Inc. | 1.94B | - | - | - |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.96% | 156,380 | 1.13B |
| 291 | VIR | Vir Biotechnology, Inc. | 1.91B | 2.08% | 1,737,300 | 303.23M |
| 292 | IMCR | Immunocore Holdings plc | 1.89B | -1.00% | 270,098 | 430.78M |
| 293 | DMRA | Damora Therapeutics, Inc. | 1.89B | 0.69% | 171,252 | - |
| 294 | SEPN | Septerna, Inc. | 1.89B | 0.55% | 266,542 | 98.88M |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.85B | -1.69% | 412,754 | 481.07M |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -1.43% | 10,050,083 | 54.86M |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.84B | -0.61% | 2,443,903 | 59.51M |
| 298 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -1.12% | 310,836 | 1.30M |
| 299 | LMAT | LeMaitre Vascular, Inc. | 1.82B | 0.07% | 208,742 | 262.43M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.54% | 1,222,505 | 106.69M |
| 301 | SGRY | Surgery Partners, Inc. | 1.81B | -0.78% | 1,371,836 | 3.37B |
| 302 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 0.35% | 652,350 | 252.25M |
| 303 | PSNL | Personalis, Inc. | 1.79B | -1.64% | 4,881,359 | 69.67M |
| 304 | FTRE | Fortrea Holdings Inc. | 1.79B | 1.78% | 1,323,440 | 2.68B |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.79B | 0.08% | 445,866 | 105.60M |
| 306 | BRVE | Braveheart Bio, Inc. | 1.79B | 0.36% | 127,847 | - |
| 307 | INSP | Inspire Medical Systems, Inc. | 1.76B | -1.59% | 315,772 | 898.74M |
| 308 | ALVO | Alvotech | 1.74B | -0.61% | 967,675 | 494.61M |
| 309 | AAPG | Ascentage Pharma Group International | 1.73B | 10.83% | 15,520 | 94.61M |
| 310 | ANAB | AnaptysBio, Inc. | 1.70B | -1.22% | 533,687 | 232.39M |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.64B | 0.40% | 445,006 | - |
| 312 | AVLN | Avalyn Pharma Inc. | 1.62B | -1.43% | 129,003 | - |
| 313 | ABSI | Absci Corporation | 1.62B | 2.17% | 3,210,172 | 1.56M |
| 314 | TRAX | First Tracks Biotherapeutics, Inc. | 1.60B | 1.24% | 352,564 | - |
| 315 | APMD | Apnimed, Inc. | 1.59B | -2.91% | 421,715 | 120.15M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.59B | -3.31% | 692,410 | 20.00M |
| 317 | AGL | agilon health, inc. | 1.58B | -1.63% | 176,434 | 5.92B |
| 318 | LTGO | Latigo Biotherapeutics, Inc. | 1.58B | 3.61% | 235,526 | - |
| 319 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | -1.41% | 317,632 | 978.38M |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.57B | 0.13% | 361,739 | 1.86B |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.57B | -0.92% | 1,273,489 | 335.41M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.56B | -0.34% | 253,973 | - |
| 323 | ARDT | Ardent Health, Inc. | 1.55B | -2.14% | 361,042 | 6.41B |
| 324 | LBRX | LB Pharmaceuticals Inc | 1.54B | -0.57% | 256,064 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.45% | 299,970 | - |
| 326 | SDGR | Schrödinger, Inc. | 1.53B | 4.83% | 861,419 | 259.04M |
| 327 | OMCL | Omnicell, Inc. | 1.52B | -0.12% | 436,648 | 1.25B |
| 328 | INVA | Innoviva, Inc. | 1.51B | -1.32% | 488,063 | 440.00M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | -2.86% | 198,310 | 95.13M |
| 330 | CNMD | CONMED Corporation | 1.51B | -0.32% | 327,125 | 1.37B |
| 331 | SLBT | SL Science Holding Limited | 1.51B | 1.54% | 37,044 | 3.27M |
| 332 | FRNM | Freenome, Inc. | 1.50B | -1.06% | 348,684 | 35.41M |
| 333 | INNV | InnovAge Holding Corp. | 1.50B | -0.09% | 167,213 | 949.17M |
| 334 | NVAX | Novavax, Inc. | 1.49B | -1.74% | 2,560,358 | 413.80M |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.49B | 0.14% | 1,031,167 | 1.04B |
| 336 | OMDA | Omada Health, Inc. | 1.49B | 1.29% | 1,107,287 | 309.76M |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.48B | 1.59% | 1,564,902 | 815.05M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.48B | 0.72% | 432,706 | 1.52B |
| 339 | AZTA | Azenta, Inc. | 1.47B | 0.12% | 423,554 | 613.81M |
| 340 | REPL | Replimune Group, Inc. | 1.47B | -1.76% | 1,670,526 | - |
| 341 | AKTS | Aktis Oncology, Inc. | 1.46B | -1.24% | 210,624 | 10.06M |
| 342 | CGEM | Cullinan Therapeutics, Inc. | 1.45B | -1.09% | 471,907 | - |
| 343 | HROW | Harrow, Inc. | 1.44B | -2.01% | 442,315 | 275.59M |
| 344 | ENOV | Enovis Corporation | 1.43B | -1.66% | 486,346 | 2.30B |
| 345 | ANRO | Alto Neuroscience, Inc. | 1.42B | -0.63% | 320,031 | - |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.42B | -1.22% | 1,060,958 | - |
| 347 | SPTX | Seaport Therapeutics, Inc. | 1.41B | -5.71% | 128,656 | - |
| 348 | SVRA | Savara Inc. | 1.40B | -2.14% | 1,595,280 | - |
| 349 | OMER | Omeros Corporation | 1.39B | 5.65% | 1,756,247 | 38.42M |
| 350 | VOR | Vor Biopharma Inc. | 1.39B | -0.59% | 622,121 | - |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.37B | -1.00% | 447,171 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.36B | 2.45% | 425,995 | 3.43B |
| 353 | MGTX | MeiraGTx Holdings plc | 1.36B | -2.88% | 955,114 | 397.50M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.35B | -0.19% | 342,543 | - |
| 355 | NUTX | Nutex Health Inc. | 1.33B | -1.03% | 105,269 | 846.72M |
| 356 | MLTX | MoonLake Immunotherapeutics | 1.32B | -0.58% | 1,099,382 | - |
| 357 | PNTG | The Pennant Group, Inc. | 1.32B | -1.20% | 318,638 | 1.10B |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.31B | -0.18% | 449,753 | 1.65B |
| 359 | MNKD | MannKind Corporation | 1.31B | -0.73% | 1,748,670 | 393.63M |
| 360 | AORT | Artivion, Inc. | 1.30B | -1.95% | 440,840 | 471.47M |
| 361 | CERT | Certara, Inc. | 1.28B | 2.31% | 1,402,036 | 421.75M |
| 362 | IMTX | Immatics N.V. | 1.28B | -0.74% | 742,184 | 47.65M |
| 363 | CRON | Cronos Group Inc. | 1.25B | -4.51% | 2,269,027 | 179.09M |
| 364 | ODTX | Odyssey Therapeutics, Inc. | 1.24B | 1.37% | 141,356 | 99.00K |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -0.07% | 508,072 | - |
| 366 | SANA | Sana Biotechnology, Inc. | 1.22B | -1.68% | 1,511,967 | - |
| 367 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | -0.42% | 1,080,949 | 28.73M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.20B | -3.84% | 1,089,584 | 785.23M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 1.06% | 158,057 | 804.27M |
| 370 | PRCT | PROCEPT BioRobotics Corporation | 1.18B | -2.23% | 1,107,308 | 337.34M |
| 371 | KURA | Kura Oncology, Inc. | 1.17B | 0.92% | 2,366,273 | 77.23M |
| 372 | IVA | Inventiva S.A. | 1.17B | 1.66% | 865,632 | 7.94M |
| 373 | BVS | Bioventus Inc. | 1.16B | -1.29% | 435,797 | 581.85M |
| 374 | TDOC | Teladoc Health, Inc. | 1.16B | 0.47% | 2,478,607 | 2.49B |
| 375 | JANX | Janux Therapeutics, Inc. | 1.15B | -0.58% | 577,311 | 24.00M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | -1.92% | 226,659 | 1.04B |
| 377 | STAA | STAAR Surgical Company | 1.12B | -2.06% | 565,298 | 339.59M |
| 378 | OPK | OPKO Health, Inc. | 1.12B | -0.66% | 2,709,939 | 587.90M |
| 379 | IRMD | IRADIMED CORPORATION | 1.11B | -0.54% | 76,199 | 86.34M |
| 380 | SLDB | Solid Biosciences Inc. | 1.09B | 4.22% | 988,927 | - |
| 381 | AVTX | Avalo Therapeutics, Inc. | 1.08B | -2.43% | 420,139 | 59.00K |
| 382 | CADL | Candel Therapeutics, Inc. | 1.05B | 3.54% | 1,180,181 | - |
| 383 | QDEL | QuidelOrtho Corporation | 1.05B | 2.75% | 816,040 | 2.67B |
| 384 | CSTL | Castle Biosciences, Inc. | 1.05B | 0.53% | 251,211 | 357.28M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.43% | 1,616,417 | 41.47M |
| 386 | PCRX | Pacira BioSciences, Inc. | 1.03B | -0.27% | 413,334 | 746.16M |
| 387 | IMMX | Immix Biopharma, Inc. | 1.02B | 1.71% | 1,510,925 | - |
| 388 | ABUS | Arbutus Biopharma Corporation | 1.02B | -0.39% | 3,575,868 | 181.72M |
| 389 | WVE | Wave Life Sciences, Inc. | 1.02B | -1.34% | 2,949,828 | 65.37M |
| 390 | ANNX | Annexon, Inc. | 995.29M | 5.21% | 3,022,694 | - |
| 391 | GERN | Geron Corporation | 982.98M | - | 7,883,087 | 204.56M |
| 392 | GMRS | GMR Solutions Inc. | 976.96M | -1.95% | 362,072 | 5.88B |
| 393 | HELP | Cybin Inc. | 967.32M | -2.86% | 797,530 | - |
| 394 | DSGN | Design Therapeutics, Inc. | 954.37M | -2.18% | 389,182 | - |
| 395 | ARDX | Ardelyx, Inc. | 951.90M | -0.26% | 2,285,846 | 450.89M |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 944.10M | -0.55% | 383,336 | - |
| 397 | AMPH | Amphastar Pharmaceuticals, Inc. | 930.73M | -0.64% | 259,781 | 730.02M |
| 398 | ATTO | Attovia Therapeutics, Inc. | 923.40M | 9.77% | 137,305 | 1.35M |
| 399 | ANL | Adlai Nortye Ltd. | 922.18M | -4.91% | 137,004 | 18.06M |
| 400 | GLAS | Glass House Brands Inc. | 921.69M | -5.96% | 308,801 | 176.98M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 906.75M | -0.48% | 1,408,994 | 8.22M |
| 402 | SGP | SpyGlass Pharma, Inc. | 900.75M | 1.09% | 66,047 | - |
| 403 | CBLL | CeriBell, Inc. | 896.90M | -0.34% | 160,556 | 101.96M |
| 404 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 487,328 | 104.31M |
| 405 | BBNX | Beta Bionics, Inc. | 879.10M | 1.03% | 1,169,445 | 119.01M |
| 406 | RIGL | Rigel Pharmaceuticals, Inc. | 875.34M | 0.82% | 210,026 | 276.79M |
| 407 | AVR | Anteris Technologies Global Corp. | 874.20M | 0.22% | 469,442 | 2.24M |
| 408 | FTH | Faeth Therapeutics, Inc. | 871.86M | 2.34% | 198,583 | - |
| 409 | CLYM | Climb Bio, Inc. | 864.99M | -6.34% | 1,552,440 | - |
| 410 | COLL | Collegium Pharmaceutical, Inc. | 860.77M | -3.89% | 850,081 | 808.21M |
| 411 | SIBN | SI-BONE, Inc. | 860.52M | -1.18% | 629,256 | 213.60M |
| 412 | DBVT | DBV Technologies S.A. | 854.24M | -0.76% | 130,918 | 5.04M |
| 413 | INMD | InMode Ltd. | 853.01M | -0.60% | 322,445 | 374.63M |
| 414 | HSTM | HealthStream, Inc. | 842.99M | 0.24% | 118,384 | 321.12M |
| 415 | ACHV | Achieve Life Sciences, Inc. | 841.74M | -1.09% | 987,653 | - |
| 416 | AHG | Akso Health Group | 839.57M | -1.01% | 8,005 | 13.83M |
| 417 | PHAR | Pharming Group N.V. | 832.78M | -1.42% | 6,428 | 366.48M |
| 418 | FDMT | 4D Molecular Therapeutics, Inc. | 823.69M | -4.18% | 717,546 | 92.01M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 820.73M | 0.76% | 319,793 | - |
| 420 | SLN | Silence Therapeutics plc | 809.82M | -0.59% | 283,574 | 615.00K |
| 421 | AURA | Aura Biosciences, Inc. | 798.53M | -0.39% | 440,768 | - |
| 422 | VREX | Varex Imaging Corporation | 779.32M | 0.05% | 591,084 | 865.00M |
| 423 | AHCO | AdaptHealth Corp. | 773.77M | 2.29% | 2,251,913 | 3.36B |
| 424 | STTK | Shattuck Labs, Inc. | 767.78M | -3.16% | 542,881 | 1.00M |
| 425 | OCS | Oculis Holding AG | 767.33M | -4.16% | 111,280 | 1.45M |
| 426 | MNPR | Monopar Therapeutics Inc. | 764.78M | 0.19% | 142,825 | - |
| 427 | DRUG | Bright Minds Biosciences Inc. | 760.37M | -2.73% | 61,692 | - |
| 428 | CBIO | Crescent Biopharma, Inc. | 760.15M | -1.44% | 76,669 | 11.88M |
| 429 | SOPH | SOPHiA GENETICS SA | 759.34M | 4.57% | 613,129 | 86.17M |
| 430 | NGNE | Neurogene Inc. | 757.63M | -1.43% | 132,067 | 925.00K |
| 431 | CTMX | CytomX Therapeutics, Inc. | 745.22M | 3.01% | 2,391,344 | 18.30M |
| 432 | OBX | Obsidian Therapeutics, Inc. | 738.28M | -7.39% | 65,062 | - |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 736.00M | -0.86% | 385,265 | - |
| 434 | PHR | Phreesia, Inc. | 733.09M | 2.24% | 644,916 | 495.59M |
| 435 | ALLO | Allogene Therapeutics, Inc. | 722.08M | 2.45% | 4,965,318 | 4.64M |
| 436 | TECX | Tectonic Therapeutic, Inc. | 717.46M | 2.03% | 278,104 | - |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 710.11M | 1.94% | 1,047,090 | 239.66M |
| 438 | ASMB | Assembly Biosciences, Inc. | 708.55M | -1.75% | 192,092 | 74.85M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 0.45% | 25,343 | 109.82M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 703.70M | 0.94% | 620,351 | 136.07M |
| 441 | EVO | Evotec SE | 700.73M | 1.03% | 31,275 | 819.47M |
| 442 | IRWD | Ironwood Pharmaceuticals, Inc. | 700.62M | -1.17% | 844,488 | 389.32M |
| 443 | MPLT | MapLight Therapeutics, Inc. | 696.92M | -2.49% | 741,533 | - |
| 444 | SSII | SS Innovations International, Inc. | 685.32M | -4.20% | 46,144 | 52.40M |
| 445 | AGMB | AgomAb Therapeutics NV | 681.59M | -3.08% | 154,165 | - |
| 446 | OABI | OmniAb, Inc. | 670.25M | -4.16% | 1,281,964 | 38.46M |
| 447 | VSTM | Verastem, Inc. | 668.36M | -0.14% | 1,300,202 | 87.53M |
| 448 | SGMT | Sagimet Biosciences Inc. | 668.21M | -1.01% | 581,691 | - |
| 449 | MDXG | MiMedx Group, Inc. | 657.38M | 2.04% | 1,050,356 | 355.17M |
| 450 | CTEV | Claritev Corporation | 657.22M | 3.22% | 155,267 | 994.67M |
| 451 | PRLD | Prelude Therapeutics Incorporated | 652.99M | -3.35% | 364,168 | 22.42M |
| 452 | ANGO | AngioDynamics, Inc. | 652.64M | 0.64% | 295,447 | 320.17M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 648.96M | 1.35% | 432,418 | - |
| 454 | CRMD | CorMedix Inc. | 647.72M | -0.95% | 703,880 | 462.25M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 647.64M | -4.27% | 3,661,794 | 54.09M |
| 456 | PRME | Prime Medicine, Inc. | 647.57M | 1.68% | 1,832,772 | 4.07M |
| 457 | STLN | Starling Oncology, Inc. | 646.15M | -3.35% | 1,590,563 | 587.24M |
| 458 | ALT | Altimmune, Inc. | 630.24M | 2.86% | 2,080,968 | 31.00K |
| 459 | AUTL | Autolus Therapeutics plc | 628.14M | 1.29% | 1,229,634 | 117.39M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 623.98M | -3.84% | 261,657 | - |
| 461 | VALN | Valneva SE | 621.92M | -2.02% | 21,498 | 163.30M |
| 462 | TLRY | Tilray Brands, Inc. | 619.76M | -1.51% | 2,872,629 | 915.45M |
| 463 | RGNX | REGENXBIO Inc. | 618.54M | -0.11% | 874,895 | 174.48M |
| 464 | KIDS | OrthoPediatrics Corp. | 608.88M | -2.95% | 184,157 | 252.72M |
| 465 | BLSM | BlossomHill Therapeutics, Inc. | 606.74M | 7.26% | 102,308 | - |
| 466 | ARVN | Arvinas, Inc. | 604.17M | -0.86% | 527,001 | 316.70M |
| 467 | CTKB | Cytek Biosciences, Inc. | 600.52M | 1.09% | 651,350 | 206.71M |
| 468 | SPRY | ARS Pharmaceuticals, Inc. | 599.67M | - | 1,190,304 | 116.93M |
| 469 | EOLS | Evolus, Inc. | 586.53M | 1.14% | 1,194,847 | 316.49M |
| 470 | CAPR | Capricor Therapeutics, Inc. | 584.88M | 7.48% | 12,034,148 | 11.13M |
| 471 | WEAV | Weave Communications, Inc. | 583.99M | -0.14% | 7,569,571 | 257.79M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 583.75M | 1.44% | 218,266 | 251.00K |
| 473 | BWAY | BrainsWay Ltd. | 582.47M | 0.70% | 96,560 | 60.70M |
| 474 | CABA | Cabaletta Bio, Inc. | 573.06M | 4.00% | 3,800,445 | - |
| 475 | OVID | Ovid Therapeutics Inc. | 572.22M | 1.74% | 1,614,572 | 1.58M |
| 476 | DCTH | Delcath Systems, Inc. | 568.71M | -0.06% | 402,570 | 95.42M |
| 477 | ZURA | Zura Bio Limited | 560.60M | -2.34% | 873,010 | - |
| 478 | PROK | ProKidney Corp. | 550.23M | 4.60% | 1,103,540 | 818.00K |
| 479 | FLGT | Fulgent Genetics, Inc. | 548.93M | 0.71% | 212,518 | 323.93M |
| 480 | CERS | Cerus Corporation | 548.15M | -0.73% | 805,368 | 221.55M |
| 481 | SRTA | Strata Critical Medical, Inc. | 545.84M | 0.82% | 777,028 | 255.98M |
| 482 | SCTX | Scribe Therapeutics Inc. | 544.05M | -9.02% | 194,645 | 36.28M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 534.33M | 0.35% | 432,407 | - |
| 484 | ENTX | Entera Bio Ltd. | 533.28M | -3.45% | 240,572 | 42.00K |
| 485 | TCMD | Tactile Systems Technology, Inc. | 523.49M | -1.70% | 203,245 | 350.31M |
| 486 | RZLT | Rezolute, Inc. | 520.24M | -1.19% | 642,819 | - |
| 487 | EVH | Evolent Health, Inc. | 518.94M | -6.71% | 2,397,954 | 2.10B |
| 488 | EDIT | Editas Medicine, Inc. | 506.81M | 3.77% | 2,664,978 | 47.01M |
| 489 | CCCC | C4 Therapeutics, Inc. | 504.40M | -3.30% | 1,988,436 | 35.04M |
| 490 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 491 | SENS | Senseonics Holdings, Inc. | 497.02M | 0.64% | 359,647 | 48.55M |
| 492 | EVMN | Evommune, Inc. | 489.22M | -4.46% | 252,447 | 10.00M |
| 493 | DNA | Ginkgo Bioworks Holdings, Inc. | 488.89M | 0.41% | 757,143 | 132.42M |
| 494 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.92M | -0.94% | 208,527 | - |
| 495 | NRC | NRC Health | 486.85M | 0.05% | 67,796 | 140.00M |
| 496 | CLPT | ClearPoint Neuro, Inc. | 486.24M | -2.63% | 440,443 | 42.28M |
| 497 | NPCE | NeuroPace, Inc. | 485.00M | -3.75% | 148,088 | 106.99M |
| 498 | RLMD | Relmada Therapeutics, Inc. | 482.15M | -0.66% | 496,482 | - |
| 499 | PACB | Pacific Biosciences of California, Inc. | 481.79M | -0.64% | 6,277,924 | 159.27M |
| 500 | QTTB | Q32 Bio Inc. | 480.78M | -0.19% | 203,335 | 53.74M |